ID   HEXA_HUMAN              Reviewed;         529 AA.
AC   P06865; B4DKE7; E7ENH7; Q53HS8; Q6AI32;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 203.
DE   RecName: Full=Beta-hexosaminidase subunit alpha;
DE            EC=3.2.1.52;
DE   AltName: Full=Beta-N-acetylhexosaminidase subunit alpha;
DE            Short=Hexosaminidase subunit A;
DE   AltName: Full=N-acetyl-beta-glucosaminidase subunit alpha;
DE   Flags: Precursor;
GN   Name=HEXA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT VAL-436.
RX   PubMed=2933746; DOI=10.1073/pnas.82.23.7830;
RA   Myerowitz R., Piekarz R., Neufeld E.F., Shows T.B., Suzuki K.;
RT   "Human beta-hexosaminidase alpha chain: coding sequence and homology
RT   with the beta chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:7830-7834(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-436.
RX   PubMed=2952641;
RA   Proia R.L., Soravia E.;
RT   "Organization of the gene encoding the human beta-hexosaminidase
RT   alpha-chain.";
RL   J. Biol. Chem. 262:5677-5681(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT VAL-436.
RX   PubMed=1833974;
RA   Triggs-Raine B.L., Akerman B.R., Clarke J.T.R., Gravel R.A.;
RT   "Sequence of DNA flanking the exons of the HEXA gene, and
RT   identification of mutations in Tay-Sachs disease.";
RL   Am. J. Hum. Genet. 49:1041-1054(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-436.
RC   TISSUE=Adipose tissue;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   PSEUDODEFICIENCY TRP-249 AND VAL-436.
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H.,
RA   Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K.,
RA   Ottenwaelder B., Poustka A., Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R.,
RA   Fahey J., Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G.,
RA   Johnson E., Jones C., Kamat A., Kaur A., Locke D.P., Madan A.,
RA   Munson G., Jaffe D.B., Lui A., Macdonald P., Mauceli E., Naylor J.W.,
RA   Nesbitt R., Nicol R., O'Leary S.B., Ratcliffe A., Rounsley S., She X.,
RA   Sneddon K.M.B., Stewart S., Sougnez C., Stone S.M., Topham K.,
RA   Vincent D., Wang S., Zimmer A.R., Birren B.W., Hood L., Lander E.S.,
RA   Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human
RT   chromosome 15.";
RL   Nature 440:671-675(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT
RP   VAL-436.
RC   TISSUE=Brain, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 40-529 (ISOFORM 1), AND VARIANT VAL-436.
RX   PubMed=3013851;
RA   Korneluk R.G., Mahuran D.J., Neote K., Klavins M.H., O'Dowd B.F.,
RA   Tropak M., Willard H.F., Anderson M.-J., Lowden J.A., Gravel R.A.;
RT   "Isolation of cDNA clones coding for the alpha-subunit of human beta-
RT   hexosaminidase. Extensive homology between the alpha- and beta-
RT   subunits and studies on Tay-Sachs disease.";
RL   J. Biol. Chem. 261:8407-8413(1986).
RN   [10]
RP   PROTEIN SEQUENCE OF 89-99.
RX   PubMed=2965147;
RA   Mahuran D.J., Neote K., Klavins M.H., Leung A., Gravel R.A.;
RT   "Proteolytic processing of pro-alpha and pro-beta precursors from
RT   human beta-hexosaminidase. Generation of the mature alpha and beta a
RT   beta b subunits.";
RL   J. Biol. Chem. 263:4612-4618(1988).
RN   [11]
RP   PROTEIN SEQUENCE OF 96-105, AND STRUCTURE OF CARBOHYDRATES.
RX   PubMed=2971395; DOI=10.1021/bi00414a041;
RA   O'Dowd B.F., Cumming D.A., Gravel R.A., Mahuran D.J.;
RT   "Oligosaccharide structure and amino acid sequence of the major
RT   glycopeptides of mature human beta-hexosaminidase.";
RL   Biochemistry 27:5216-5226(1988).
RN   [12]
RP   GLYCOSYLATION AT ASN-115; ASN-157 AND ASN-295, AND MUTAGENESIS OF
RP   ASN-115; ASN-157 AND ASN-295.
RX   PubMed=1533633;
RA   Weitz G., Proia R.L.;
RT   "Analysis of the glycosylation and phosphorylation of the alpha-
RT   subunit of the lysosomal enzyme, beta-hexosaminidase A, by site-
RT   directed mutagenesis.";
RL   J. Biol. Chem. 267:10039-10044(1992).
RN   [13]
RP   ACTIVE SITES.
RX   PubMed=8652542; DOI=10.1021/bi960246+;
RA   Tse R., Vavougios G., Hou Y., Mahuran D.J.;
RT   "Identification of an active acidic residue in the catalytic site of
RT   beta-hexosaminidase.";
RL   Biochemistry 35:7599-7607(1996).
RN   [14]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-157 AND ASN-295.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of
RT   multiple enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [17]
RP   3D-STRUCTURE MODELING.
RX   PubMed=8673609; DOI=10.1038/nsb0796-638;
RA   Tews I., Perrakis A., Oppenheim A., Dauter Z., Wilson K.S.,
RA   Vorgias C.E.;
RT   "Bacterial chitobiase structure provides insight into catalytic
RT   mechanism and the basis of Tay-Sachs disease.";
RL   Nat. Struct. Biol. 3:638-648(1996).
RN   [18]
RP   REVIEW ON VARIANTS.
RX   PubMed=1825792; DOI=10.1016/0925-4439(91)90044-A;
RA   Mahuran D.J.;
RT   "The biochemistry of HEXA and HEXB gene mutations causing GM2
RT   gangliosidosis.";
RL   Biochim. Biophys. Acta 1096:87-94(1991).
RN   [19]
RP   REVIEW ON VARIANTS.
RX   PubMed=9090523;
RX   DOI=10.1002/(SICI)1098-1004(1997)9:3<195::AID-HUMU1>3.0.CO;2-7;
RA   Myerowitz R.;
RT   "Tay-Sachs disease-causing mutations and neutral polymorphisms in the
RT   Hex A gene.";
RL   Hum. Mutat. 9:195-208(1997).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF 23-529 IN COMPLEX WITH HEXB,
RP   GLYCOSYLATION AT ASN-115; ASN-157 AND ASN-295, AND DISULFIDE BONDS.
RX   PubMed=16698036; DOI=10.1016/j.jmb.2006.04.004;
RA   Lemieux M.J., Mark B.L., Cherney M.M., Withers S.G., Mahuran D.J.,
RA   James M.N.;
RT   "Crystallographic structure of human beta-hexosaminidase A:
RT   interpretation of Tay-Sachs mutations and loss of GM2 ganglioside
RT   hydrolysis.";
RL   J. Mol. Biol. 359:913-929(2006).
RN   [21]
RP   VARIANT GM2G1 LYS-482.
RX   PubMed=2970528; DOI=10.1111/j.1471-4159.1988.tb01836.x;
RA   Nakano T., Muscillo M., Ohno K., Hoffman A.J., Suzuki K.;
RT   "A point mutation in the coding sequence of the beta-hexosaminidase
RT   alpha gene results in defective processing of the enzyme protein in an
RT   unusual GM2-gangliosidosis variant.";
RL   J. Neurochem. 51:984-987(1988).
RN   [22]
RP   VARIANT GM2G1 SER-269.
RX   PubMed=2522679; DOI=10.1126/science.2522679;
RA   Navon R., Proia R.L.;
RT   "The mutations in Ashkenazi Jews with adult GM2 gangliosidosis, the
RT   adult form of Tay-Sachs disease.";
RL   Science 243:1471-1474(1989).
RN   [23]
RP   VARIANT GM2G1 CYS-420.
RX   PubMed=2144098;
RA   Tanaka A., Punnett H.H., Suzuki K.;
RT   "A new point mutation in the beta-hexosaminidase alpha subunit gene
RT   responsible for infantile Tay-Sachs disease in a non-Jewish Caucasian
RT   patient (a Kpn mutant).";
RL   Am. J. Hum. Genet. 47:568-574(1990).
RN   [24]
RP   VARIANT GM2G1 HIS-504, AND CHARACTERIZATION OF VARIANT GM2G1 HIS-504.
RX   PubMed=2140574;
RA   Paw B.H., Moskowitz S.M., Uhrhammer N., Wright N., Kaback M.M.,
RA   Neufeld E.F.;
RT   "Juvenile GM2 gangliosidosis caused by substitution of histidine for
RT   arginine at position 499 or 504 of the alpha-subunit of beta-
RT   hexosaminidase.";
RL   J. Biol. Chem. 265:9452-9457(1990).
RN   [25]
RP   VARIANTS GM2G1 PHE-210 AND CYS-504.
RX   PubMed=1837283; DOI=10.1016/0888-7543(91)90109-R;
RA   Akli S., Lacorte J.-M., Poenaru L., Khan A.;
RT   "Seven novel Tay-Sachs mutations detected by chemical mismatch
RT   cleavage of PCR-amplified cDNA fragments.";
RL   Genomics 11:124-134(1991).
RN   [26]
RP   VARIANT GM2G1 GLY-320 DEL, AND VARIANTS ASP-399 AND VAL-436.
RX   PubMed=1532289;
RA   Mules E.H., Hayflick S., Miller C.S., Reynolds L.W., Thomas G.H.;
RT   "Six novel deleterious and three neutral mutations in the gene
RT   encoding the alpha-subunit of hexosaminidase A in non-Jewish
RT   individuals.";
RL   Am. J. Hum. Genet. 50:834-841(1992).
RN   [27]
RP   VARIANT PSEUDODEFICIENCY TRP-247.
RX   PubMed=1384323;
RA   Triggs-Raine B.L., Mules E.H., Kaback M.M., Lim-Steele J.S.T.,
RA   Dowling C.E., Akerman B.R., Natowicz M.R., Grebner E.E., Navon R.,
RA   Welch J.P., Greenberg C.R., Thomas G.H., Gravel R.A.;
RT   "A pseudodeficiency allele common in non-Jewish Tay-Sachs carriers:
RT   implications for carrier screening.";
RL   Am. J. Hum. Genet. 51:793-801(1992).
RN   [28]
RP   VARIANTS GM2G1 TRP-170 AND HIS-258.
RX   PubMed=1302612; DOI=10.1093/hmg/1.9.759;
RA   Fernandes M., Kaplan F., Natowicz M., Prence E., Kolodny E.,
RA   Kaback M., Hechtman P.;
RT   "A new Tay-Sachs disease B1 allele in exon 7 in two compound
RT   heterozygotes each with a second novel mutation.";
RL   Hum. Mol. Genet. 1:759-761(1992).
RN   [29]
RP   VARIANT GM2G1 ASP-250.
RX   PubMed=1301189; DOI=10.1002/humu.1380010106;
RA   Trop I., Kaplan F., Brown C., Mahuran D., Hechtman P.;
RT   "A glycine250--> aspartate substitution in the alpha-subunit of
RT   hexosaminidase A causes juvenile-onset Tay-Sachs disease in a
RT   Lebanese-Canadian family.";
RL   Hum. Mutat. 1:35-39(1992).
RN   [30]
RP   VARIANT GM2G1 ARG-485.
RX   PubMed=1301190; DOI=10.1002/humu.1380010107;
RA   Akalin N., Shi H.-P., Vavougios G., Hechtman P., Lo W., Scriver C.R.,
RA   Mahuran D., Kaplan F.;
RT   "Novel Tay-Sachs disease mutations from China.";
RL   Hum. Mutat. 1:40-46(1992).
RN   [31]
RP   VARIANT PSEUDODEFICIENCY TRP-249.
RX   PubMed=7902672;
RA   Cao Z., Natowicz M.R., Kaback M.M., Lim-Steele J.S.T., Prence E.M.,
RA   Brown D., Chabot T., Triggs-Raine B.L.;
RT   "A second mutation associated with apparent beta-hexosaminidase A
RT   pseudodeficiency: identification and frequency estimation.";
RL   Am. J. Hum. Genet. 53:1198-1205(1993).
RN   [32]
RP   VARIANTS GM2G1.
RX   PubMed=8490625; DOI=10.1093/hmg/2.1.61;
RA   Akli S., Chomel J.-C., Lacorte J.-M., Bachner L., Poenaru A.,
RA   Poenaru L.;
RT   "Ten novel mutations in the HEXA gene in non-Jewish Tay-Sachs
RT   patients.";
RL   Hum. Mol. Genet. 2:61-67(1993).
RN   [33]
RP   VARIANT GM2G1 SER-25.
RX   PubMed=8445615; DOI=10.1136/jmg.30.2.123;
RA   Harmon D.L., Gardner-Medwin D., Stirling J.L.;
RT   "Two new mutations in a late infantile Tay-Sachs patient are both in
RT   exon 1 of the beta-hexosaminidase alpha subunit gene.";
RL   J. Med. Genet. 30:123-128(1993).
RN   [34]
RP   VARIANTS GM2G1 PHE-335 AND 347-ASP--GLU-352 DEL.
RX   PubMed=7951261; DOI=10.1002/humu.1380040112;
RA   Tomczak J., Grebner E.E.;
RT   "Three novel beta-hexosaminidase A mutations in obligate carriers of
RT   Tay-Sachs disease.";
RL   Hum. Mutat. 4:71-72(1994).
RN   [35]
RP   VARIANTS GM2G1 TYR-458 AND GLN-484.
RX   PubMed=7837766; DOI=10.1007/BF00711597;
RA   Tanaka A., Sakazaki H., Murakami H., Isshiki G., Suzuki K.;
RT   "Molecular genetics of Tay-Sachs disease in Japan.";
RL   J. Inherit. Metab. Dis. 17:593-600(1994).
RN   [36]
RP   VARIANTS GM2G1 SER-196 AND SER-250.
RX   PubMed=7717398;
RA   Triggs-Raine B.L., Richard M., Wasel N., Prence E.M., Natowicz M.R.;
RT   "Mutational analyses of Tay-Sachs disease: studies on Tay-Sachs
RT   carriers of French Canadian background living in New England.";
RL   Am. J. Hum. Genet. 56:870-879(1995).
RN   [37]
RP   VARIANT GM2G1 GLY-166.
RX   PubMed=8581357; DOI=10.1006/bmme.1995.1018;
RA   Peleg L., Meltzer F., Karpati M., Goldman B.;
RT   "GM2 gangliosidosis B1 variant: biochemical and molecular
RT   characterization of hexosaminidase A.";
RL   Biochem. Mol. Med. 54:126-132(1995).
RN   [38]
RP   VARIANT GM2G1 MET-391.
RX   PubMed=7898712; DOI=10.1212/WNL.45.3.539;
RA   Navon R., Khosravi R., Korczyn T., Masson M., Sonnino S., Fardeau M.,
RA   Eymard B., Lefevre N., Turpin J.C., Rondot P.;
RT   "A new mutation in the HEXA gene associated with a spinal muscular
RT   atrophy phenotype.";
RL   Neurology 45:539-543(1995).
RN   [39]
RP   VARIANT GM2G1 HIS-180.
RX   PubMed=8757036; DOI=10.1212/WNL.47.2.547;
RA   de Gasperi R., Gama Sosa M.A., Battistini S., Yeretsian J.,
RA   Raghavan S., Zelnik N., Leshinsky E., Kolodny E.H.;
RT   "Late-onset GM2 gangliosidosis: Ashkenazi Jewish family with an exon 5
RT   mutation (Tyr180-->His) in the Hex A alpha-chain gene.";
RL   Neurology 47:547-552(1996).
RN   [40]
RP   VARIANTS GM2G1 PHE-127; PHE-226; ASP-269 AND VAL-314.
RX   PubMed=9150157;
RA   Akerman B.R., Natowicz M.R., Kaback M.M., Loyer M., Campeau E.,
RA   Gravel R.A.;
RT   "Novel mutations and DNA-based screening in non-Jewish carriers of
RT   Tay-Sachs disease.";
RL   Am. J. Hum. Genet. 60:1099-1106(1997).
RN   [41]
RP   VARIANTS GM2G1 GLN-170; PHE-304 DEL AND LYS-482.
RX   PubMed=9338583;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:4<295::AID-HUMU5>3.0.CO;2-G;
RA   Kaufman M., Grinshpun-Cohen J., Karpati M., Peleg L., Goldman B.,
RA   Akstein E., Adam A., Navon R.;
RT   "Tay-Sachs disease and HEXA mutations among Moroccan Jews.";
RL   Hum. Mutat. 10:295-300(1997).
RN   [42]
RP   VARIANT GM2G1 ARG-455.
RX   PubMed=9375850;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:5<359::AID-HUMU4>3.3.CO;2-G;
RA   Ribeiro M.G., Pinto R.A., Suzuki K., Sa Miranda M.C.;
RT   "Two novel (1334delC and 1363G to A, G455R) mutations in exon 12 of
RT   the beta-hexosaminidase alpha-chain gene in two Portuguese patients.";
RL   Hum. Mutat. 10:359-360(1997).
RN   [43]
RP   VARIANT GM2G1 PRO-279.
RX   PubMed=9401008;
RX   DOI=10.1002/(SICI)1098-1004(1997)10:6<451::AID-HUMU6>3.3.CO;2-G;
RA   Drucker L., Hemli J.A., Navon R.;
RT   "Two mutated HEXA alleles in a Druze patient with late-infantile Tay-
RT   Sachs disease.";
RL   Hum. Mutat. 10:451-457(1997).
RN   [44]
RP   VARIANT GM2G1 CYS-474.
RX   PubMed=9603435;
RX   DOI=10.1002/(SICI)1098-1004(1998)11:6<432::AID-HUMU3>3.0.CO;2-Z;
RA   Petroulakis E., Cao Z., Clarke J.T.R., Mahuran D.J., Lee G.,
RA   Triggs-Raine B.;
RT   "W474C amino acid substitution affects early processing of the alpha-
RT   subunit of beta-hexosaminidase A and is associated with subacute G(M2)
RT   gangliosidosis.";
RL   Hum. Mutat. 11:432-442(1998).
RN   [45]
RP   VARIANTS GM2G1 LEU-252; SER-295; CYS-420; CYS-499 AND HIS-499.
RX   PubMed=14566483; DOI=10.1007/s10038-003-0080-9;
RA   Tanaka A., Hoang L.T., Nishi Y., Maniwa S., Oka M., Yamano T.;
RT   "Different attenuated phenotypes of GM2 gangliosidosis variant B in
RT   Japanese patients with HEXA mutations at codon 499, and five novel
RT   mutations responsible for infantile acute form.";
RL   J. Hum. Genet. 48:571-574(2003).
RN   [46]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-436, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [47]
RP   VARIANTS GM2G1 LYS-114; TRP-170; ASN-322; TYR-322; PRO-393; VAL-462
RP   AND ARG-478.
RX   PubMed=22723944; DOI=10.1371/journal.pone.0039122;
RA   Mistri M., Tamhankar P.M., Sheth F., Sanghavi D., Kondurkar P.,
RA   Patil S., Idicula-Thomas S., Gupta S., Sheth J.;
RT   "Identification of novel mutations in HEXA gene in children affected
RT   with Tay Sachs disease from India.";
RL   PLoS ONE 7:E39122-E39122(2012).
RN   [48]
RP   CHARACTERIZATION OF VARIANTS GM2G1 SER-269 AND LYS-482.
RX   PubMed=27682588; DOI=10.1091/mbc.E16-01-0012;
RA   Dersh D., Iwamoto Y., Argon Y.;
RT   "Tay Sachs disease mutations in HEXA target the alpha chain of
RT   hexosaminidase A to ER-associated degradation.";
RL   Mol. Biol. Cell 27:3813-3827(2016).
CC   -!- FUNCTION: Responsible for the degradation of GM2 gangliosides, and
CC       a variety of other molecules containing terminal N-acetyl
CC       hexosamines, in the brain and other tissues. The form B is active
CC       against certain oligosaccharides. The form S has no measurable
CC       activity.
CC   -!- CATALYTIC ACTIVITY: Hydrolysis of terminal non-reducing N-acetyl-
CC       D-hexosamine residues in N-acetyl-beta-D-hexosaminides.
CC   -!- SUBUNIT: There are 3 forms of beta-hexosaminidase: hexosaminidase
CC       A is a trimer composed of one subunit alpha, one subunit beta
CC       chain A and one subunit beta chain B; hexosaminidase B is a
CC       tetramer of two subunit beta chains A and two subunit beta chains
CC       B; hexosaminidase S is a homodimer of two alpha subunits. The two
CC       beta chains are derived from the cleavage of the beta subunit.
CC       {ECO:0000269|PubMed:16698036}.
CC   -!- SUBCELLULAR LOCATION: Lysosome.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P06865-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P06865-2; Sequence=VSP_056657, VSP_056658, VSP_056659;
CC         Note=No experimental confirmation available.;
CC   -!- PTM: N-linked glycan at Asn-115 consists of Man(3)-GlcNAc(2).
CC       {ECO:0000269|PubMed:1533633, ECO:0000269|PubMed:16698036,
CC       ECO:0000269|PubMed:19159218}.
CC   -!- DISEASE: GM2-gangliosidosis 1 (GM2G1) [MIM:272800]: An autosomal
CC       recessive lysosomal storage disease marked by the accumulation of
CC       GM2 gangliosides in the neuronal cells. It is characterized by GM2
CC       gangliosides accumulation in the absence of HEXA activity, leading
CC       to neurodegeneration and, in the infantile form, death in early
CC       childhood. It exists in several forms: infantile (most common and
CC       most severe), juvenile and adult (late-onset).
CC       {ECO:0000269|PubMed:1301189, ECO:0000269|PubMed:1301190,
CC       ECO:0000269|PubMed:1302612, ECO:0000269|PubMed:14566483,
CC       ECO:0000269|PubMed:1532289, ECO:0000269|PubMed:1837283,
CC       ECO:0000269|PubMed:2140574, ECO:0000269|PubMed:2144098,
CC       ECO:0000269|PubMed:22723944, ECO:0000269|PubMed:2522679,
CC       ECO:0000269|PubMed:27682588, ECO:0000269|PubMed:2970528,
CC       ECO:0000269|PubMed:7717398, ECO:0000269|PubMed:7837766,
CC       ECO:0000269|PubMed:7898712, ECO:0000269|PubMed:7951261,
CC       ECO:0000269|PubMed:8445615, ECO:0000269|PubMed:8490625,
CC       ECO:0000269|PubMed:8581357, ECO:0000269|PubMed:8757036,
CC       ECO:0000269|PubMed:9150157, ECO:0000269|PubMed:9338583,
CC       ECO:0000269|PubMed:9375850, ECO:0000269|PubMed:9401008,
CC       ECO:0000269|PubMed:9603435}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyl hydrolase 20 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=HEXAdb; Note=HEXA mutation database;
CC       URL="http://www.hexdb.mcgill.ca/?Topic=HEXAdb";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M16424; AAB00965.1; -; Genomic_DNA.
DR   EMBL; M16411; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16412; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16413; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16414; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16415; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16416; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16417; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16418; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16419; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16420; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16421; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16422; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; M16423; AAB00965.1; JOINED; Genomic_DNA.
DR   EMBL; S62076; AAD13932.1; -; Genomic_DNA.
DR   EMBL; S62047; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62049; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62051; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62053; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62055; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62057; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62059; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62061; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62063; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62066; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62068; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62070; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; S62072; AAD13932.1; JOINED; Genomic_DNA.
DR   EMBL; AK296528; BAG59159.1; -; mRNA.
DR   EMBL; AK222502; BAD96222.1; -; mRNA.
DR   EMBL; CR627386; CAH10482.1; -; mRNA.
DR   EMBL; AC009690; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC018927; AAH18927.1; -; mRNA.
DR   EMBL; BC084537; AAH84537.1; -; mRNA.
DR   EMBL; M13520; AAA51827.1; -; mRNA.
DR   CCDS; CCDS10243.1; -. [P06865-1]
DR   PIR; A23561; AOHUBA.
DR   RefSeq; NP_000511.2; NM_000520.5. [P06865-1]
DR   RefSeq; NP_001305754.1; NM_001318825.1.
DR   UniGene; Hs.604479; -.
DR   UniGene; Hs.709495; -.
DR   PDB; 1QBC; Model; -; A=109-529.
DR   PDB; 2GJX; X-ray; 2.80 A; A/D/E/H=23-529.
DR   PDB; 2GK1; X-ray; 3.25 A; A/C/E/G=23-529.
DR   PDBsum; 1QBC; -.
DR   PDBsum; 2GJX; -.
DR   PDBsum; 2GK1; -.
DR   ProteinModelPortal; P06865; -.
DR   SMR; P06865; -.
DR   BioGrid; 109322; 37.
DR   IntAct; P06865; 14.
DR   MINT; MINT-1393072; -.
DR   STRING; 9606.ENSP00000268097; -.
DR   BindingDB; P06865; -.
DR   ChEMBL; CHEMBL1250415; -.
DR   SwissLipids; SLP:000001416; -. [P06865-1]
DR   CAZy; GH20; Glycoside Hydrolase Family 20.
DR   iPTMnet; P06865; -.
DR   PhosphoSitePlus; P06865; -.
DR   SwissPalm; P06865; -.
DR   BioMuta; HEXA; -.
DR   DMDM; 311033393; -.
DR   EPD; P06865; -.
DR   MaxQB; P06865; -.
DR   PaxDb; P06865; -.
DR   PeptideAtlas; P06865; -.
DR   PRIDE; P06865; -.
DR   DNASU; 3073; -.
DR   Ensembl; ENST00000268097; ENSP00000268097; ENSG00000213614. [P06865-1]
DR   GeneID; 3073; -.
DR   KEGG; hsa:3073; -.
DR   UCSC; uc002aun.5; human. [P06865-1]
DR   CTD; 3073; -.
DR   DisGeNET; 3073; -.
DR   GeneCards; HEXA; -.
DR   GeneReviews; HEXA; -.
DR   H-InvDB; HIX0012407; -.
DR   HGNC; HGNC:4878; HEXA.
DR   HPA; HPA054583; -.
DR   MalaCards; HEXA; -.
DR   MIM; 272800; phenotype.
DR   MIM; 606869; gene.
DR   neXtProt; NX_P06865; -.
DR   OpenTargets; ENSG00000213614; -.
DR   Orphanet; 309192; Tay-Sachs disease, B variant, adult form.
DR   Orphanet; 309178; Tay-Sachs disease, B variant, infantile form.
DR   Orphanet; 309185; Tay-Sachs disease, B variant, juvenile form.
DR   Orphanet; 309239; Tay-Sachs disease, B1 variant.
DR   PharmGKB; PA29256; -.
DR   eggNOG; KOG2499; Eukaryota.
DR   eggNOG; COG3525; LUCA.
DR   GeneTree; ENSGT00390000008107; -.
DR   HOGENOM; HOG000157972; -.
DR   HOVERGEN; HBG005961; -.
DR   InParanoid; P06865; -.
DR   KO; K12373; -.
DR   PhylomeDB; P06865; -.
DR   TreeFam; TF313036; -.
DR   BioCyc; MetaCyc:ENSG00000140495-MONOMER; -.
DR   BRENDA; 3.2.1.169; 2681.
DR   Reactome; R-HSA-1660662; Glycosphingolipid metabolism.
DR   Reactome; R-HSA-2022857; Keratan sulfate degradation.
DR   Reactome; R-HSA-2024101; CS/DS degradation.
DR   Reactome; R-HSA-2160916; Hyaluronan uptake and degradation.
DR   SABIO-RK; P06865; -.
DR   EvolutionaryTrace; P06865; -.
DR   GeneWiki; HEXA; -.
DR   GenomeRNAi; 3073; -.
DR   PRO; PR:P06865; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   Bgee; ENSG00000213614; -.
DR   CleanEx; HS_HEXA; -.
DR   ExpressionAtlas; P06865; baseline and differential.
DR   Genevisible; P06865; HS.
DR   GO; GO:0042582; C:azurophil granule; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043202; C:lysosomal lumen; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004563; F:beta-N-acetylhexosaminidase activity; TAS:Reactome.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:MGI.
DR   GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro.
DR   GO; GO:0030207; P:chondroitin sulfate catabolic process; TAS:Reactome.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0006687; P:glycosphingolipid metabolic process; TAS:Reactome.
DR   GO; GO:0030214; P:hyaluronan catabolic process; TAS:Reactome.
DR   GO; GO:0042340; P:keratan sulfate catabolic process; TAS:Reactome.
DR   InterPro; IPR025705; Beta_hexosaminidase_sua/sub.
DR   InterPro; IPR029018; Chitobiase/Hex_dom_2-like.
DR   InterPro; IPR015883; Glyco_hydro_20_cat.
DR   InterPro; IPR017853; Glycoside_hydrolase_SF.
DR   InterPro; IPR029019; HEX_eukaryotic_N.
DR   Pfam; PF00728; Glyco_hydro_20; 1.
DR   Pfam; PF14845; Glycohydro_20b2; 1.
DR   PIRSF; PIRSF001093; B-hxosamndse_ab_euk_; 1.
DR   PRINTS; PR00738; GLHYDRLASE20.
DR   SUPFAM; SSF51445; SSF51445; 1.
DR   SUPFAM; SSF55545; SSF55545; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome;
KW   Direct protein sequencing; Disease mutation; Disulfide bond;
KW   Gangliosidosis; Glycoprotein; Glycosidase; Hydrolase; Lysosome;
KW   Neurodegeneration; Polymorphism; Reference proteome; Signal; Zymogen.
FT   SIGNAL        1     22       {ECO:0000269|PubMed:2952641}.
FT   PROPEP       23     88       {ECO:0000269|PubMed:2965147}.
FT                                /FTId=PRO_0000011993.
FT   CHAIN        89    529       Beta-hexosaminidase subunit alpha.
FT                                /FTId=PRO_0000011994.
FT   REGION      423    424       Critical for hydrolyzis GM2 gangliosides.
FT   ACT_SITE    323    323       Proton donor. {ECO:0000250}.
FT   CARBOHYD    115    115       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:1533633,
FT                                ECO:0000269|PubMed:16698036}.
FT   CARBOHYD    157    157       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:1533633,
FT                                ECO:0000269|PubMed:16698036,
FT                                ECO:0000269|PubMed:19159218}.
FT   CARBOHYD    295    295       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000269|PubMed:1533633,
FT                                ECO:0000269|PubMed:16698036,
FT                                ECO:0000269|PubMed:19159218}.
FT   DISULFID     58    104       {ECO:0000269|PubMed:16698036}.
FT   DISULFID    277    328       {ECO:0000269|PubMed:16698036}.
FT   DISULFID    505    522       {ECO:0000269|PubMed:16698036}.
FT   VAR_SEQ       1    192       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056657.
FT   VAR_SEQ     359    360       LL -> YP (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056658.
FT   VAR_SEQ     361    529       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056659.
FT   VARIANT      25     25       P -> S (in GM2G1; late infantile).
FT                                {ECO:0000269|PubMed:8445615}.
FT                                /FTId=VAR_003202.
FT   VARIANT      39     39       L -> R (in GM2G1; infantile;
FT                                dbSNP:rs121907979).
FT                                /FTId=VAR_003203.
FT   VARIANT     114    114       E -> K (in GM2G1; unknown pathological
FT                                significance).
FT                                {ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_077497.
FT   VARIANT     127    127       L -> F (in GM2G1).
FT                                {ECO:0000269|PubMed:9150157}.
FT                                /FTId=VAR_022439.
FT   VARIANT     127    127       L -> R (in GM2G1; infantile;
FT                                dbSNP:rs121907975).
FT                                /FTId=VAR_003204.
FT   VARIANT     166    166       R -> G (in GM2G1; late infantile).
FT                                {ECO:0000269|PubMed:8581357}.
FT                                /FTId=VAR_003205.
FT   VARIANT     170    170       R -> Q (in GM2G1; infantile; inactive or
FT                                unstable protein; dbSNP:rs121907957).
FT                                {ECO:0000269|PubMed:9338583}.
FT                                /FTId=VAR_003206.
FT   VARIANT     170    170       R -> W (in GM2G1; infantile;
FT                                dbSNP:rs121907972).
FT                                {ECO:0000269|PubMed:1302612,
FT                                ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_003207.
FT   VARIANT     178    178       R -> C (in GM2G1; infantile; inactive
FT                                protein; dbSNP:rs121907953).
FT                                /FTId=VAR_003208.
FT   VARIANT     178    178       R -> H (in GM2G1; infantile; inactive
FT                                protein; dbSNP:rs28941770).
FT                                /FTId=VAR_003209.
FT   VARIANT     178    178       R -> L (in GM2G1; infantile;
FT                                dbSNP:rs28941770).
FT                                /FTId=VAR_003210.
FT   VARIANT     180    180       Y -> H (in GM2G1; dbSNP:rs28941771).
FT                                {ECO:0000269|PubMed:8757036}.
FT                                /FTId=VAR_003211.
FT   VARIANT     192    192       V -> L (in GM2G1; infantile;
FT                                dbSNP:rs387906310).
FT                                /FTId=VAR_003212.
FT   VARIANT     196    196       N -> S (in GM2G1; dbSNP:rs753862880).
FT                                {ECO:0000269|PubMed:7717398}.
FT                                /FTId=VAR_003213.
FT   VARIANT     197    197       K -> T (in GM2G1; dbSNP:rs121907973).
FT                                /FTId=VAR_003214.
FT   VARIANT     200    200       V -> M (in GM2G1; dbSNP:rs1800429).
FT                                /FTId=VAR_003215.
FT   VARIANT     204    204       H -> R (in GM2G1; infantile;
FT                                dbSNP:rs121907976).
FT                                /FTId=VAR_003216.
FT   VARIANT     210    210       S -> F (in GM2G1; infantile;
FT                                dbSNP:rs121907961).
FT                                {ECO:0000269|PubMed:1837283}.
FT                                /FTId=VAR_003217.
FT   VARIANT     211    211       F -> S (in GM2G1; infantile;
FT                                dbSNP:rs121907974).
FT                                /FTId=VAR_003218.
FT   VARIANT     226    226       S -> F (in GM2G1; dbSNP:rs769866128).
FT                                {ECO:0000269|PubMed:9150157}.
FT                                /FTId=VAR_022440.
FT   VARIANT     247    247       R -> W (in HEXA pseudodeficiency;
FT                                dbSNP:rs121907970).
FT                                {ECO:0000269|PubMed:1384323}.
FT                                /FTId=VAR_003219.
FT   VARIANT     249    249       R -> W (in HEXA pseudodeficiency;
FT                                dbSNP:rs138058578).
FT                                {ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:7902672}.
FT                                /FTId=VAR_003220.
FT   VARIANT     250    250       G -> D (in GM2G1; juvenile;
FT                                dbSNP:rs121907959).
FT                                {ECO:0000269|PubMed:1301189}.
FT                                /FTId=VAR_003221.
FT   VARIANT     250    250       G -> S (in GM2G1).
FT                                {ECO:0000269|PubMed:7717398}.
FT                                /FTId=VAR_003222.
FT   VARIANT     252    252       R -> H (in GM2G1; dbSNP:rs762255098).
FT                                /FTId=VAR_003223.
FT   VARIANT     252    252       R -> L (in GM2G1).
FT                                {ECO:0000269|PubMed:14566483}.
FT                                /FTId=VAR_017188.
FT   VARIANT     258    258       D -> H (in GM2G1; infantile;
FT                                dbSNP:rs121907971).
FT                                {ECO:0000269|PubMed:1302612}.
FT                                /FTId=VAR_003224.
FT   VARIANT     269    269       G -> D (in GM2G1).
FT                                {ECO:0000269|PubMed:9150157}.
FT                                /FTId=VAR_022441.
FT   VARIANT     269    269       G -> S (in GM2G1; late onset; inhibited
FT                                subunit dissociation; loss of processing
FT                                to a mature form; increased degradation;
FT                                dbSNP:rs121907954).
FT                                {ECO:0000269|PubMed:2522679,
FT                                ECO:0000269|PubMed:27682588}.
FT                                /FTId=VAR_003225.
FT   VARIANT     279    279       S -> P (in GM2G1; late infantile).
FT                                {ECO:0000269|PubMed:9401008}.
FT                                /FTId=VAR_003226.
FT   VARIANT     293    293       S -> I (in dbSNP:rs1054374).
FT                                /FTId=VAR_058477.
FT   VARIANT     295    295       N -> S (in GM2G1; dbSNP:rs199578185).
FT                                {ECO:0000269|PubMed:14566483}.
FT                                /FTId=VAR_017189.
FT   VARIANT     301    301       M -> R (in GM2G1; infantile;
FT                                dbSNP:rs121907977).
FT                                /FTId=VAR_003227.
FT   VARIANT     304    304       Missing (in GM2G1; infantile; Moroccan
FT                                Jewish). {ECO:0000269|PubMed:9338583}.
FT                                /FTId=VAR_003228.
FT   VARIANT     314    314       D -> V (in GM2G1).
FT                                {ECO:0000269|PubMed:9150157}.
FT                                /FTId=VAR_022442.
FT   VARIANT     320    320       Missing (in GM2G1; late infantile).
FT                                {ECO:0000269|PubMed:1532289}.
FT                                /FTId=VAR_003229.
FT   VARIANT     322    322       D -> N (in GM2G1).
FT                                {ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_077498.
FT   VARIANT     322    322       D -> Y (in GM2G1; dbSNP:rs772180415).
FT                                {ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_077499.
FT   VARIANT     335    335       I -> F (in GM2G1).
FT                                {ECO:0000269|PubMed:7951261}.
FT                                /FTId=VAR_003230.
FT   VARIANT     347    352       Missing (in GM2G1).
FT                                {ECO:0000269|PubMed:7951261}.
FT                                /FTId=VAR_003231.
FT   VARIANT     391    391       V -> M (in GM2G1; mild; associated with
FT                                spinal muscular atrophy).
FT                                {ECO:0000269|PubMed:7898712}.
FT                                /FTId=VAR_003232.
FT   VARIANT     393    393       R -> P (in GM2G1).
FT                                {ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_077500.
FT   VARIANT     399    399       N -> D (in dbSNP:rs1800430).
FT                                {ECO:0000269|PubMed:1532289}.
FT                                /FTId=VAR_003233.
FT   VARIANT     420    420       W -> C (in GM2G1; infantile; inactive
FT                                protein; dbSNP:rs121907958).
FT                                {ECO:0000269|PubMed:14566483,
FT                                ECO:0000269|PubMed:2144098}.
FT                                /FTId=VAR_003234.
FT   VARIANT     436    436       I -> V (in dbSNP:rs1800431).
FT                                {ECO:0000244|PubMed:21269460,
FT                                ECO:0000269|PubMed:1532289,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:17974005,
FT                                ECO:0000269|PubMed:1833974,
FT                                ECO:0000269|PubMed:2933746,
FT                                ECO:0000269|PubMed:2952641,
FT                                ECO:0000269|PubMed:3013851,
FT                                ECO:0000269|Ref.5}.
FT                                /FTId=VAR_003235.
FT   VARIANT     454    454       G -> S (in GM2G1; infantile;
FT                                dbSNP:rs121907978).
FT                                /FTId=VAR_003236.
FT   VARIANT     455    455       G -> R (in GM2G1; late infantile).
FT                                {ECO:0000269|PubMed:9375850}.
FT                                /FTId=VAR_003237.
FT   VARIANT     458    458       C -> Y (in GM2G1; infantile).
FT                                {ECO:0000269|PubMed:7837766}.
FT                                /FTId=VAR_003238.
FT   VARIANT     462    462       E -> V (in GM2G1; dbSNP:rs863225434).
FT                                {ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_077501.
FT   VARIANT     474    474       W -> C (in GM2G1; subacute;
FT                                dbSNP:rs121907981).
FT                                {ECO:0000269|PubMed:9603435}.
FT                                /FTId=VAR_003239.
FT   VARIANT     478    478       G -> R (in GM2G1).
FT                                {ECO:0000269|PubMed:22723944}.
FT                                /FTId=VAR_077502.
FT   VARIANT     482    482       E -> K (in GM2G1; infantile; loss of
FT                                processing to a mature form; increased
FT                                degradation; dbSNP:rs121907952).
FT                                {ECO:0000269|PubMed:27682588,
FT                                ECO:0000269|PubMed:2970528,
FT                                ECO:0000269|PubMed:9338583}.
FT                                /FTId=VAR_003240.
FT   VARIANT     484    484       L -> Q (in GM2G1; infantile).
FT                                {ECO:0000269|PubMed:7837766}.
FT                                /FTId=VAR_003241.
FT   VARIANT     485    485       W -> R (in GM2G1; infantile;
FT                                dbSNP:rs121907968).
FT                                {ECO:0000269|PubMed:1301190}.
FT                                /FTId=VAR_003242.
FT   VARIANT     499    499       R -> C (in GM2G1; infantile;
FT                                dbSNP:rs121907966).
FT                                {ECO:0000269|PubMed:14566483}.
FT                                /FTId=VAR_003243.
FT   VARIANT     499    499       R -> H (in GM2G1; juvenile;
FT                                dbSNP:rs121907956).
FT                                {ECO:0000269|PubMed:14566483}.
FT                                /FTId=VAR_003244.
FT   VARIANT     504    504       R -> C (in GM2G1; infantile;
FT                                dbSNP:rs28942071).
FT                                {ECO:0000269|PubMed:1837283}.
FT                                /FTId=VAR_003245.
FT   VARIANT     504    504       R -> H (in GM2G1; juvenile; fails to
FT                                associate with the beta-subunit to form
FT                                the enzymatically active heterodimer;
FT                                dbSNP:rs121907955).
FT                                {ECO:0000269|PubMed:2140574}.
FT                                /FTId=VAR_003246.
FT   MUTAGEN     115    115       N->Q: No change of the catalytic activity
FT                                associated with the alpha-chain. No
FT                                catalytic activity associated with the
FT                                alpha-chain; when associated with Q-157
FT                                and Q-295. {ECO:0000269|PubMed:1533633}.
FT   MUTAGEN     157    157       N->Q: No change of the catalytic activity
FT                                associated with the alpha-chain. No
FT                                catalytic activity associated with the
FT                                alpha-chain; when associated with Q-115
FT                                and Q-295. {ECO:0000269|PubMed:1533633}.
FT   MUTAGEN     295    295       N->Q: No change of the catalytic activity
FT                                associated with the alpha-chain. No
FT                                catalytic activity associated with the
FT                                alpha-chain; when associated with Q-115
FT                                and Q-157. {ECO:0000269|PubMed:1533633}.
FT   CONFLICT    331    331       S -> P (in Ref. 5; BAD96222).
FT                                {ECO:0000305}.
FT   STRAND       28     31       {ECO:0000244|PDB:2GJX}.
FT   STRAND       36     39       {ECO:0000244|PDB:2GJX}.
FT   TURN         41     43       {ECO:0000244|PDB:2GJX}.
FT   STRAND       45     48       {ECO:0000244|PDB:2GJX}.
FT   HELIX        59     73       {ECO:0000244|PDB:2GJX}.
FT   STRAND       93    100       {ECO:0000244|PDB:2GJX}.
FT   STRAND      104    106       {ECO:0000244|PDB:2GJX}.
FT   STRAND      116    123       {ECO:0000244|PDB:2GJX}.
FT   STRAND      125    131       {ECO:0000244|PDB:2GJX}.
FT   HELIX       132    145       {ECO:0000244|PDB:2GJX}.
FT   STRAND      146    148       {ECO:0000244|PDB:2GJX}.
FT   STRAND      154    157       {ECO:0000244|PDB:2GJX}.
FT   STRAND      159    163       {ECO:0000244|PDB:2GJX}.
FT   STRAND      168    175       {ECO:0000244|PDB:2GJX}.
FT   TURN        176    178       {ECO:0000244|PDB:2GJX}.
FT   HELIX       183    195       {ECO:0000244|PDB:2GJX}.
FT   STRAND      200    204       {ECO:0000244|PDB:2GJX}.
FT   STRAND      216    218       {ECO:0000244|PDB:2GK1}.
FT   HELIX       220    225       {ECO:0000244|PDB:2GJX}.
FT   STRAND      226    228       {ECO:0000244|PDB:2GK1}.
FT   TURN        229    231       {ECO:0000244|PDB:2GJX}.
FT   HELIX       236    248       {ECO:0000244|PDB:2GJX}.
FT   STRAND      252    256       {ECO:0000244|PDB:2GJX}.
FT   STRAND      260    262       {ECO:0000244|PDB:2GJX}.
FT   TURN        264    269       {ECO:0000244|PDB:2GJX}.
FT   STRAND      274    290       {ECO:0000244|PDB:2GJX}.
FT   HELIX       295    311       {ECO:0000244|PDB:2GJX}.
FT   STRAND      314    318       {ECO:0000244|PDB:2GJX}.
FT   HELIX       327    331       {ECO:0000244|PDB:2GJX}.
FT   HELIX       333    341       {ECO:0000244|PDB:2GJX}.
FT   HELIX       349    364       {ECO:0000244|PDB:2GJX}.
FT   TURN        365    367       {ECO:0000244|PDB:2GJX}.
FT   STRAND      369    373       {ECO:0000244|PDB:2GJX}.
FT   HELIX       374    378       {ECO:0000244|PDB:2GJX}.
FT   STRAND      388    391       {ECO:0000244|PDB:2GJX}.
FT   STRAND      394    398       {ECO:0000244|PDB:2GJX}.
FT   HELIX       400    409       {ECO:0000244|PDB:2GJX}.
FT   STRAND      413    416       {ECO:0000244|PDB:2GJX}.
FT   STRAND      426    428       {ECO:0000244|PDB:2GJX}.
FT   HELIX       431    436       {ECO:0000244|PDB:2GJX}.
FT   HELIX       446    449       {ECO:0000244|PDB:2GJX}.
FT   STRAND      452    459       {ECO:0000244|PDB:2GJX}.
FT   TURN        466    468       {ECO:0000244|PDB:2GJX}.
FT   HELIX       469    473       {ECO:0000244|PDB:2GJX}.
FT   HELIX       476    485       {ECO:0000244|PDB:2GJX}.
FT   HELIX       493    509       {ECO:0000244|PDB:2GJX}.
FT   STRAND      517    519       {ECO:0000244|PDB:2GJX}.
SQ   SEQUENCE   529 AA;  60703 MW;  DACB3E3992E57A47 CRC64;
     MTSSRLWFSL LLAAAFAGRA TALWPWPQNF QTSDQRYVLY PNNFQFQYDV SSAAQPGCSV
     LDEAFQRYRD LLFGSGSWPR PYLTGKRHTL EKNVLVVSVV TPGCNQLPTL ESVENYTLTI
     NDDQCLLLSE TVWGALRGLE TFSQLVWKSA EGTFFINKTE IEDFPRFPHR GLLLDTSRHY
     LPLSSILDTL DVMAYNKLNV FHWHLVDDPS FPYESFTFPE LMRKGSYNPV THIYTAQDVK
     EVIEYARLRG IRVLAEFDTP GHTLSWGPGI PGLLTPCYSG SEPSGTFGPV NPSLNNTYEF
     MSTFFLEVSS VFPDFYLHLG GDEVDFTCWK SNPEIQDFMR KKGFGEDFKQ LESFYIQTLL
     DIVSSYGKGY VVWQEVFDNK VKIQPDTIIQ VWREDIPVNY MKELELVTKA GFRALLSAPW
     YLNRISYGPD WKDFYIVEPL AFEGTPEQKA LVIGGEACMW GEYVDNTNLV PRLWPRAGAV
     AERLWSNKLT SDLTFAYERL SHFRCELLRR GVQAQPLNVG FCEQEFEQT
//
